TREACE MED CONCEPTS (TMCI) insider trading activity (SEC Form 4). Over the trailing 90 days, TMCI insiders filed 5 purchases totalling $1.2M and 0 sales totalling $0 — net BUYING of $1.2M. Most recent filing: Jun 12, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.
| Filed | Insider | Role | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | Treace John T. | CEO, 10% | P Purchase | — | $4.03 | $99K | filing |
| Jun 11, 2026 | Treace John T. | CEO, 10% | P Purchase | — | $4.03 | $211K | filing |
| Jun 1, 2026 | Treace John T. | CEO, 10% | P Purchase | — | $3.56 | $178K | filing |
| May 28, 2026 | Treace John T. | CEO, 10% | P Purchase | — | $2.95 | $341K | filing |
| May 14, 2026 | Treace John T. | CEO, 10% | P Purchase | — | $2.44 | $376K | filing |